| BAFYX | VRTIX | BAFYX / VRTIX | |
| Total Expense Ratio | 0.94 | 0.07 | 1,343% |
| Annual Report Gross Expense Ratio | 1.05 | 0.07 | 1,500% |
| Fund Existence | 4 years | 15 years | - |
| Gain YTD | 7.059 | 14.503 | 49% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 5000000 | 20% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 102M | 14.3B | 1% |
| Annual Yield % from dividends | 0.57 | 1.17 | 49% |
| Returns for 1 year | 5.55 | 13.07 | 42% |
| Returns for 3 years | 34.87 | 46.54 | 75% |
| Returns for 5 years | N/A | 29.26 | - |
| Returns for 10 years | N/A | 130.53 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ELIL | 28.43 | 0.36 | +1.28% |
| Direxion Daily LLY Bull 2X Shares | |||
| AVMA | 66.80 | 0.21 | +0.32% |
| Avantis Moderate Allocation ETF | |||
| DINT | 28.88 | 0.07 | +0.25% |
| Davis Select International ETF | |||
| HYTI | 19.76 | 0.03 | +0.18% |
| FT Vest High Yield & Target Income ETF | |||
| ARKG | 30.18 | 0.04 | +0.13% |
| ARK Genomic Revolution ETF | |||